| Code | CSB-RA019049MB2HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is designed as a research-grade biosimilar to reference antibody ABO-21009, targeting PTPRC (Protein Tyrosine Phosphatase Receptor Type C), also known as CD45. PTPRC is a critical transmembrane protein tyrosine phosphatase exclusively expressed on all nucleated hematopoietic cells, playing an essential role in regulating antigen receptor signaling in T and B lymphocytes. This protein functions as a key modulator of immune cell activation, differentiation, and proliferation by dephosphorylating Src family kinases. Dysregulation of PTPRC expression and function has been implicated in various immunological disorders, autoimmune diseases, and hematological malignancies, making it an important marker for immune cell characterization and a valuable target for immunological research.
As a biosimilar to ABO-21009, this antibody provides researchers with a reliable tool for investigating PTPRC biology and immune cell function. It serves as a valuable reagent for studies exploring lymphocyte signaling pathways, immune system development, and disease mechanisms involving aberrant immune responses. This product supports diverse research applications in immunology, hematology, and oncology.
There are currently no reviews for this product.